Activated Clotting Time Requires Adaptation Across Altered Measurement Devices: Determination of Appropriate Range During Atrial Fibrillation Ablation

Background Methods for measuring activated clotting time (ACT) are not yet standardized. Objectives To adjust and compare values between two measurement systems and to optimize ACT during atrial fibrillation (AF) ablation. Methods Two systems were compared: electromagnetic detection using a rotating...

Full description

Saved in:
Bibliographic Details
Main Authors: Haruna Sakanoue RN, Hirosuke Yamaji MD, Sayaka Okamoto RN, Kumi Okano RN, Yuka Fujita RN, Shunichi Higashiya MD, Takashi Murakami MD, Satoshi Hirohata MD, Shozo Kusachi MD
Format: Article
Language:English
Published: SAGE Publishing 2025-03-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296251332938
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850209454605205504
author Haruna Sakanoue RN
Hirosuke Yamaji MD
Sayaka Okamoto RN
Kumi Okano RN
Yuka Fujita RN
Shunichi Higashiya MD
Takashi Murakami MD
Satoshi Hirohata MD
Shozo Kusachi MD
author_facet Haruna Sakanoue RN
Hirosuke Yamaji MD
Sayaka Okamoto RN
Kumi Okano RN
Yuka Fujita RN
Shunichi Higashiya MD
Takashi Murakami MD
Satoshi Hirohata MD
Shozo Kusachi MD
author_sort Haruna Sakanoue RN
collection DOAJ
description Background Methods for measuring activated clotting time (ACT) are not yet standardized. Objectives To adjust and compare values between two measurement systems and to optimize ACT during atrial fibrillation (AF) ablation. Methods Two systems were compared: electromagnetic detection using a rotating tube (EM system; Hemochron Response) and photo-optical detection using a cartridge immersed in blood (PO system; ACT CA-300TM). Results ACT was measured simultaneously in 124 instances in 53 patients before and during AF ablations using both methods. A linear regression analysis showed ACT (EM system) = 1.19 × ACT (PO system) + 9.03 (p < .001, r = 0.90). Bland–Altman plots indicated an average difference of 50 s between the two systems. In 3364 ACT measurements from 1161 ablations, the EM system recorded a mean ACT of 320 ± 44 s (range 156-487 s). Estimating the target range as mean ± 1 SD range, the EM system's range was 275-365 s, in 5-s increments. The pre-ablation ACT measured on the EM system was 143 ± 28 s (115-170 s). Cardiac tamponade occurred in 4 out of 2085 ablations (0.19%) over 5 years, with ACT values ranging from 330 to 391 s on the EM system. Based on these findings, the estimated optimal ACT range for the PO system was adjusted to 225-300 s to align with the EM system's range of 275-365 s. Conclusions ACT target ranges should be system-specific, and direct extrapolation between devices is not recommended. Adjustment is clinically necessary when switching systems.
format Article
id doaj-art-d8cf734ec75a46bfbbfd99831488849c
institution OA Journals
issn 1938-2723
language English
publishDate 2025-03-01
publisher SAGE Publishing
record_format Article
series Clinical and Applied Thrombosis/Hemostasis
spelling doaj-art-d8cf734ec75a46bfbbfd99831488849c2025-08-20T02:09:59ZengSAGE PublishingClinical and Applied Thrombosis/Hemostasis1938-27232025-03-013110.1177/10760296251332938Activated Clotting Time Requires Adaptation Across Altered Measurement Devices: Determination of Appropriate Range During Atrial Fibrillation AblationHaruna Sakanoue RN0Hirosuke Yamaji MD1Sayaka Okamoto RN2Kumi Okano RN3Yuka Fujita RN4Shunichi Higashiya MD5Takashi Murakami MD6Satoshi Hirohata MD7Shozo Kusachi MD8 Department of Nursing, Okayama Heart Clinic, Okayama, Japan Heart Rhythm Center, Okayama Heart Clinic, Okayama, Japan Department of Nursing, Okayama Heart Clinic, Okayama, Japan Department of Nursing, Okayama Heart Clinic, Okayama, Japan Department of Nursing, Okayama Heart Clinic, Okayama, Japan Heart Rhythm Center, Okayama Heart Clinic, Okayama, Japan Heart Rhythm Center, Okayama Heart Clinic, Okayama, Japan Department of Medical Technology, , Okayama, Japan Department of Medical Technology, , Okayama, JapanBackground Methods for measuring activated clotting time (ACT) are not yet standardized. Objectives To adjust and compare values between two measurement systems and to optimize ACT during atrial fibrillation (AF) ablation. Methods Two systems were compared: electromagnetic detection using a rotating tube (EM system; Hemochron Response) and photo-optical detection using a cartridge immersed in blood (PO system; ACT CA-300TM). Results ACT was measured simultaneously in 124 instances in 53 patients before and during AF ablations using both methods. A linear regression analysis showed ACT (EM system) = 1.19 × ACT (PO system) + 9.03 (p < .001, r = 0.90). Bland–Altman plots indicated an average difference of 50 s between the two systems. In 3364 ACT measurements from 1161 ablations, the EM system recorded a mean ACT of 320 ± 44 s (range 156-487 s). Estimating the target range as mean ± 1 SD range, the EM system's range was 275-365 s, in 5-s increments. The pre-ablation ACT measured on the EM system was 143 ± 28 s (115-170 s). Cardiac tamponade occurred in 4 out of 2085 ablations (0.19%) over 5 years, with ACT values ranging from 330 to 391 s on the EM system. Based on these findings, the estimated optimal ACT range for the PO system was adjusted to 225-300 s to align with the EM system's range of 275-365 s. Conclusions ACT target ranges should be system-specific, and direct extrapolation between devices is not recommended. Adjustment is clinically necessary when switching systems.https://doi.org/10.1177/10760296251332938
spellingShingle Haruna Sakanoue RN
Hirosuke Yamaji MD
Sayaka Okamoto RN
Kumi Okano RN
Yuka Fujita RN
Shunichi Higashiya MD
Takashi Murakami MD
Satoshi Hirohata MD
Shozo Kusachi MD
Activated Clotting Time Requires Adaptation Across Altered Measurement Devices: Determination of Appropriate Range During Atrial Fibrillation Ablation
Clinical and Applied Thrombosis/Hemostasis
title Activated Clotting Time Requires Adaptation Across Altered Measurement Devices: Determination of Appropriate Range During Atrial Fibrillation Ablation
title_full Activated Clotting Time Requires Adaptation Across Altered Measurement Devices: Determination of Appropriate Range During Atrial Fibrillation Ablation
title_fullStr Activated Clotting Time Requires Adaptation Across Altered Measurement Devices: Determination of Appropriate Range During Atrial Fibrillation Ablation
title_full_unstemmed Activated Clotting Time Requires Adaptation Across Altered Measurement Devices: Determination of Appropriate Range During Atrial Fibrillation Ablation
title_short Activated Clotting Time Requires Adaptation Across Altered Measurement Devices: Determination of Appropriate Range During Atrial Fibrillation Ablation
title_sort activated clotting time requires adaptation across altered measurement devices determination of appropriate range during atrial fibrillation ablation
url https://doi.org/10.1177/10760296251332938
work_keys_str_mv AT harunasakanouern activatedclottingtimerequiresadaptationacrossalteredmeasurementdevicesdeterminationofappropriaterangeduringatrialfibrillationablation
AT hirosukeyamajimd activatedclottingtimerequiresadaptationacrossalteredmeasurementdevicesdeterminationofappropriaterangeduringatrialfibrillationablation
AT sayakaokamotorn activatedclottingtimerequiresadaptationacrossalteredmeasurementdevicesdeterminationofappropriaterangeduringatrialfibrillationablation
AT kumiokanorn activatedclottingtimerequiresadaptationacrossalteredmeasurementdevicesdeterminationofappropriaterangeduringatrialfibrillationablation
AT yukafujitarn activatedclottingtimerequiresadaptationacrossalteredmeasurementdevicesdeterminationofappropriaterangeduringatrialfibrillationablation
AT shunichihigashiyamd activatedclottingtimerequiresadaptationacrossalteredmeasurementdevicesdeterminationofappropriaterangeduringatrialfibrillationablation
AT takashimurakamimd activatedclottingtimerequiresadaptationacrossalteredmeasurementdevicesdeterminationofappropriaterangeduringatrialfibrillationablation
AT satoshihirohatamd activatedclottingtimerequiresadaptationacrossalteredmeasurementdevicesdeterminationofappropriaterangeduringatrialfibrillationablation
AT shozokusachimd activatedclottingtimerequiresadaptationacrossalteredmeasurementdevicesdeterminationofappropriaterangeduringatrialfibrillationablation